As previously mentioned, AMPs can also modulate adaptive immune responses, as is the case of bovine lactoferrin (bLf), where oral administration of this peptide as a treatment in mice lethally infected with S. typhimurium reduces mortality and leads to an increase in the total IgA, IgG, and IgM antibody response and specific Salmonella antigens generated by the infection. The gene discussed is CD79A; the disease is infection.